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ABSTRACT
Hypertension is an important condition among adults, affecting nearly one billion people worldwide. Treat-
ment with appropriate medication is a key factor in the control of hypertension and reduction in associat-
ed risk of complications. However, compliance with treatment is often sub-optimal, especially in develop- 
ing countries. The present study investigated the factors associated with self-reported compliance among 
hypertensive subjects in a poor urban community in southwest Nigeria. This community-based cross-
sectional study employed a survey of a convenience sample of 440 community residents with hyperten-
sion and eight focus-group discussions (FGDs) with a subset of the participants. Of the 440 hypertensive 
respondents, 65.2% were women, about half had no formal education, and half were traders. Over 60% 
of the respondents sought care for their condition from the hospital while only 5% visited a chemist or 
a patent medicine vendor (PMV). Only 51% of the subjects reported high compliance. Factors associated 
with high self-reported compliance included: regular clinic attendance, not using non-Western prescrip-
tion medication, and having social support from family members or friends who were concerned about 
the respondent’s hypertension or who were helpful in reminding the respondent about taking medication. 
Beliefs about cause of hypertension were not associated with compliance. The findings of the FGDs showed 
that the respondents believed hypertension is curable with the use of both orthodox and traditional medi-
cines and that a patient who ‘feels well’ could stop using antihypertensive medication. It is concluded that 
treatment compliance with antihypertensive medication remains sub-optimal in this Nigerian commu-
nity. The factors associated with high self-reported compliance were identified. More research is needed to 
evaluate how such findings can be used for the control of hypertension at the community level.
Key words: Adherence; Cardiovascular diseases; Community-based studies; Compliance; Cross-sectional 
studies; Hypertension; Nigeria
INTRODUCTION
Hypertension is an overwhelming global chal-
lenge, which ranks third as a means of reduction in 
disability-adjusted life-years (1). It affects approxi-
mately one billion people worldwide (4.5% of the 
current global burden of disease)—340 million of 
these in economically-developed and 340 million 
in economically-developing countries. Annually, it 
causes 7.1 million (or one-third of) global prevent-
able premature deaths (2,3). Due to the fact that 
hypertension is one of the most important modifi-
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able risk factors for cardiovascular diseases (4), treat-
ment that commences once it is recognized reduces 
the cardiovascular risk of the individual. Therefore, 
access to treatment with antihypertensive medica-
tion and compliance with treatment are key fac-
tors in the control of hypertension. Hypertension, 
the leading cause of mortality and the third largest 
cause of disability, is poorly controlled worldwide. 
It is estimated that almost one-half of patients drop 
out entirely from treatment within one year (5). 
The failure to control hypertension takes an unac-
ceptable toll on patients and their families. In addi-
tion to the personal cost, to the individual patient, 
uncontrolled hypertension creates huge, avoidable 
economic burdens when viewed in terms of the 
general population. 
The total number of estimated deaths resulting 
from all types of cardiovascular diseases and hyper-
tensive heart disease recorded for Nigeria in 2004 JHPN 620
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by the World Health Organization (WHO) was 
201,500 and 10,700 respectively (6) and placed Ni-
geria in the 16th position globally. Although these 
numbers are low compared to 922,700 and 229,000 
deaths reported for the USA and the United King-
dom respectively, it is clear that there is a growing 
health problem that requires an intervention. Un-
controlled blood pressure has been demonstrated 
to be a major risk factor contributing to more than 
500,000 cases of stroke and one million myocardial 
infarction cases reported each year in the United 
States alone (7). An estimated 14.55 million people, 
worldwide, aged 30-80 years, were reported to have 
died as a result of hypertension-related conditions 
in 2005, of which 7.03% were reported for sub-Sa-
haran Africa (8). 
Traditionally, the term compliance has been em-
ployed to mean the extent to which the patient, 
when taking a drug, complies with the clinician’s 
advice and follows the regimen (9). Compliance 
with treatment is defined and characterized when 
medical or health advice coincides with the indi-
vidual’s behaviour with regard to the use of medi-
cation, recommended changes in lifestyle, and 
attendance to medical appointments (10). Poor 
compliance with treatment is the most impor-
tant cause of uncontrolled blood pressure (11). 
Results of studies in the United States revealed 
that long-term compliance with treatment is always 
a problem in any chronic disease condition, and 
hypertension is no exception. More than 50% of 
patients in the United States, who were prescribed 
antihypertensive medications actually discontinued 
therapy within 12 months (12). A common reason 
given for stopping medication relates to adverse ef-
fects, although the patient’s knowledge about the 
disease, attitudes regarding treatment of an often 
asymptomatic condition, and personal health be-
liefs, together with cost of medications and avail-
ability of healthcare, are major contributors (12).
Multiple factors contribute to poor compliance with 
long-term antihypertensive therapy. Many patients 
have negative attitudes towards taking medication, 
especially if they ‘feel well’ (13). According to Jadel-
son et al., the major reasons for non-compliance 
are multi-factorial and range from lack of adequate 
guidance to socioeconomic status (14). Although 
the socioeconomic status has not consistently been 
found to be an independent predictor of compli-
ance low socioeconomic status may put patients 
in developing countries in the position of having 
to choose between competing priorities (15). Such 
priorities include demands to direct the limited re-
source available to meet the needs of other family 
members, such as children or parents, for whom 
they care. Some factors reported to have a signifi-
cant effect on compliance are: poor socioeconomic 
status (poverty), low level of education, unemploy-
ment, lack of effective social support networks, un-
stable living conditions, long distance from treat-
ment centre, high cost of transport, cultural and 
lay beliefs about illness and treatment, and forget-
fulness (16). 
The present study describes treatment-compliance 
patterns among hypertensive subjects in a Nigerian 
community and investigates the factors associated 
with good compliance, including demographic fac-
tors, beliefs about hypertension, and the availabili- 
ty of social support. 
MATERIALS AND METHODS
Study design and recruitment of sample
The study was conducted in the Idikan commu-
nity, Ibadan, a city in the southwestern Nigeria, 
as part of a larger community-based study of the 
sociological aspects of hypertension. Idikan is lo-
cated in the indigenous part of the city of Ibadan. 
Idikan is a densely-populated urban community 
within Ibadan city, with a population of 7,883 (17). 
Health facilities in the community include an out-
reach clinic run by the Department of Community 
Health of the University of Ibadan, a small dental 
clinic run by the Dental Centre of the University 
College Hospital (UCH), and private clinics. There 
are also registered patent medicine stores (pharma-
cies) and traditional healing homes in the area, 
all of which are accessible to members of the com-
munity. 
The study consisted of two components: a quan-
titative study using a community-based survey of 
hypertensive subjects and a qualitative study us-
ing focus-group discussions (FGDs) on a subset of 
the participants. The subjects for the quantitative 
study were adult (aged above 25 years) residents 
of Idikan who are known to have hypertension. 
Previous studies in the community had conducted 
household screening for hypertension, which fa-
cilitated the identification of hypertensive subjects 
in the community. The subjects for this study were 
selected from a list of known hypertensive subjects 
residing in the community that was prepared 
for one such previous hypertension study (18) 
and was updated for the present study during visits 
to the home. Four hundred and forty hypertensive 
subjects were enrolled using a consecutive sampling Volume 29 | Number 6 | December 2011 621
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method. The inclusion criteria were: (a) adults aged 
over 25 years, (b) having diagnosed hypertension 
by blood-pressure measurements, and (c) aware-
ness of the hypertension status. The only exclusion 
criteria were refusal to participate and recent (less 
than three years) diagnosis of hypertension since 
the study required respondents to have experience 
living with hypertension to be able to answer the 
questions. After obtaining informed consent, the 
subjects were administered a semi-structured ques-
tionnaire that had items on several issues, includ-
ing healthcare-seeking for their hypertension, their 
beliefs about hypertension, compliance with treat-
ment, and availability of social support (from fami- 
ly and friends). 
The goal of the FGDs was to capture in-depth infor-
mation that is complementary to the quantitative 
study (survey). This instrument guide had ques-
tions on knowledge, beliefs, perceptions, care-seek-
ing behaviour, other experiences, and compliance 
with treatment for hypertension. Specific probes 
were included on the reasons (the ‘why’ and ‘how’) 
for the respondent’s beliefs, attitude, and actions re-
garding hypertension they have. Eight FGDs were 
carried out. A purposive sampling technique was 
used for selecting participants for group discussion, 
and discussants were homogeneous in characteris-
tics within each group. There were four groups of 
males and four groups of females. Each group com-
prised 6-8 discussants. The inclusion criteria were 
individuals who were aged 45-60 years. They would 
have also been diagnosed of high blood pressure 
for 3-7 years. This allowed for having experiences 
living with hypertension while minimizing the 
forgetfulness of care-seeking over time. The key 
variable reflected in the composition of the focus 
groups was gender (male vs female). Gender is 
important because it reflects a major determinant of 
life experiences of people in the community and to 
ensure that the discussion and interaction among 
the participants in the FGDs is free and open. This 
provided relatively-homogenous focus groups that 
facilitated free and open discussion on which the 
amount of information that was elicited depends. 
Analysis of data
Management and analysis of the survey question-
naire data were done using the SPSS software 
(version 14) (SPSS Inc., Chicago, USA). Frequencies 
of the responses to the questions were computed 
and presented as percentages. The association be-
tween categorical variables was tested using the 
chi-square test. Compliance was defined using the 
question on how frequently people missed taking 
their medication. Compliance as a variable was de-
fined and used in two ways. First, compliance was 
scaled as: ‘high compliance’ (where the respond-
ent ‘never misses’ or ‘rarely misses’ to take his/her 
medication doses); ‘medium’ compliance (where 
the respondent ‘sometimes’ misses taking medica-
tion); and ‘low compliance’ (where the respondent 
‘regularly’ or ‘fairly regularly’ misses to take his/her 
medication. These variables were used for identify-
ing the factors associated with compliance in gene-
ral. Second, since the desired goal of treatment for 
hypertension is that the patient complies with tak-
ing medication for controlling his/her high blood 
pressure, ‘high compliance’ (where the respondent 
never misses or rarely misses to take his/her medi- 
cation doses) was used for identifying the variables 
associated with this goal of therapy.
Qualitative data were transcribed as soon as possible 
after each FGD session. The first author analyzed 
the qualitative data, reading through all notes and 
transcripts of the FGDs and identifying emerging 
themes relating to treatment compliance. Compu-
ter-assisted qualitative data analysis (CAQDAS) was 
also done using the ATLAS.ti software. 
Ethical approval
Ethical approval for the study protocol was ob-
tained from the Institutional Review Committee of 
the University of Ibadan/University College Hos-
pital, and written informed consent was obtained 
from all the participants. 
RESULTS
Sociodemographic characteristics
Of the 440 survey respondents, 65.2% were wom-
en. About half (51.1%) of the respondents had no 
formal education. In terms of occupation, 50% were 
traders, and about 26% were retired or not work-
ing while 11% were artisans. The respondents were 
aged 25-90 years. Their mean age was 60 [standard 
deviation (SD) 12] years. Dividing the age distribu-
tion of the respondents into 10-year bands, the   
peak age-categories were 46-55 years and 56-65 
years comprising 29.3% and 29.1% of the respond-
ents respectively. There was no significant relation-
ship between the gender of the respondents and 
their age distribution. The large majority (71%) of 
the respondents were married (Table 1). A large 
proportion (63.4%) of the respondents sought care 
for their condition from a hospital (the University 
College Hospital, the community health centre, JHPN 622
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Table 1. Demographic characteristics of survey 
respondents (n=440)
Characteristics No. %
Religion
   Islam
   Christianity
   Traditional
270
169
1
61.4
38.4
0.2
Ethnic group 
   Yoruba
   Ibo
   Isoko
434
5
1
98.6
1.1
0.2
 Level of education
   No formal education
   Primary
   Secondary
   Post-secondary
   Others (Arabic school)
225
86
49
77
3
51.1
19.5
11.1
17.5
0.7
Occupation 
    Trading
    Artisanry
    Teaching/civil service
    Not working (retired)
    Religious teaching
220
49
43
113
15
50.0
11.1
9.8
25.7
3.4
or a private hospital) while 5% visited a chemist 
or a patent medicine vendor. About 9.5% of the 
respondents who visited the hospital also used 
traditional medicine while 7.3% visited the chem-
ist and used traditional medicine. None visited a 
traditional healer exclusively.
Treatment-compliance patterns among 
respondents 
The findings of the survey showed that 77.5% of 
the respondents complied with keeping their fol-
low-up clinic appointments every time. Over one-
half (50.7%) of the respondents had high self-re-
ported compliance with treatment as they claimed 
to be taking their medication regularly whereas 
41.5% had poor self-reported compliance at differ-
ent levels ranging from regularly missing to take 
their medication to rarely taking their medication. 
Forty-six percent had taken their medication on 
the day of the study.
Eleven percent of the respondents who were non-
compliant to medication felt better and, therefore, 
had no need to continue taking their medication. 
Other factors included: forgetfulness (8.4%), lack 
of funds to purchase drugs (6.8%), side-effects of 
drugs (6.1%), and having a busy schedule but limi-
ted medication (3.6%). Only 0.5% said that they 
were tired of taking drugs. When the respondents 
perceived forgetting to take medication and side-
effects of treatment as problematic, they were 
less likely to comply with treatment.
Factors associated with good compliance 
Educational status and religion were two factors 
that often influenced knowledge, beliefs, attitudes, 
and practices relating to health and other domains 
of life. The findings showed that high self-reported 
compliance was not associated with the religion 
professed by the respondent. Almost equal percent-
ages of Muslims and Christians (57.8% vs 59.2%) 
showed high self-reported compliance (χ2=0.797, 
p=0.671). Concerning education, there was no 
clear-cut trend with high self-reported compliance 
(χ2=6.683, p=0.245), although those with prima-
ry education showed a higher frequency of high 
self-reported compliance when compared with 
respondents with other categories of educational 
levels. Beliefs about the perceived cause of hyper-
tension were not significantly associated with treat-
ment compliance. 
There was no association between believing that 
anxiety  or  stress  is  a  cause  of  hypertension  and 
high self-reported compliance. On the other hand, 
a  higher  percentage  of  those  whose  response  to 
the question on the cause of hypertension was ‘Do 
not know’ reported high compliance compared to 
those who professed to know the cause of hyper-
tension (68.8% vs 56.2%) (Table 2). Keeping regular 
clinic appointments and use/non-use of non-West-
ern  medication  were  significantly  (p<0.0001)  as-
sociated with high self-reported compliance. Table 
3 shows that the respondents who attended clinic 
appointments ‘every time’ showed the highest per-
Table 2. Relationship between beliefs about cause of hypertension and high self-reported compliance
Perceived cause 
of hypertension
Response
High self-reported compliance
No. (%) χ² p value
Anxiety Yes
No
88 (56.1)
 169 (59.7)
0.559 0.455
Stress Yes
No
69 (62.1)
 188 (57.1)
0.861 0.354
Do not know Yes
No
53 (68.8)
 204 (56.2)
4.173 0.041Volume 29 | Number 6 | December 2011 623
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centage (67.5%) of high self-reported compliance 
compared to those who attended clinic appoint-
ments ‘most times’ (42.1%) or less frequently. In 
other words, regularly keeping clinic appointments 
was positively associated with high self-reported 
compliance. In addition, the use of non-Western 
medication was also significantly related to high 
self-reported compliance: a significantly lower per-
centage of those who used non-Western medica-
tion showed higher self-reported compliance than 
those who did not (45.3% vs 63.8%, p<0.001).
The relationship between beliefs about hyperten-
sion may be important to know how well they com-
ply with treatment. These beliefs include the no-
tions that hypertension is preventable, is curable, is 
a serious condition, and can lead to complications. 
Table 3. Association between practices and high 
self-reported compliance
Practice Response
High self-reported
compliance
No. (%) χ² p value
Keeping
regular
clinic 
appoint-
ments
Every time
Most times
Sometimes
Miss most
Rarely 
keep
230 (67.5)
16 (42.1)
3 (8.8)
1 (6.7)
7 (58.3)
66.572 <0.0001
Table 4. Association between beliefs about hypertension and treatment compliance
Belief about hyper-
tension Response
Compliance (%)
χ² p value
High Medium Low
Hypertension is 
preventable
Yes
No
Do not know
57.0
42.1
64.1
13.7
31.6
15.6
29.4
26.3
20.3
8.272 0.082
Hypertension is 
curable
Yes
No
Do not know
55.6
51.6
71.3
15.8
16.1
11.5
28.6
32.2
17.2
7.744 0.101
Hypertension is 
serious
Yes
No
Do not know
58.2
50.0
65.4
14.7
25.0
15.4
27.1
25.0
19.2
1.778 0.777
Hypertension can 
lead to complica-
tions
Yes
No
Do not know
54.5
80.0
55.0
14.7
20.0
17.5
26.8
0.0
27.5
2.106 0.716
Hypertension-relat-
ed complications 
can be prevented
Yes
No
Do not know
50.0
60.3
61.0
20.7
13.6
14.6
29.3
26.2
24.4
3.774 0.437
A person on treat-
ment can stop 
taking medication 
after sometime
Yes
No
Do not know
49.5
60.2
66.7
28.3
10.7
14.3
22.2
29.1
19.1
19.658 0.001
For these analyses, their relationships with compli-
ance in general and with high self-reported compli-
ance (as defined above) were explored. Of the other 
beliefs about hypertension studied, only the belief 
that hypertension medication can be stopped after 
a while was significantly (p=0.001) associated with 
compliance in general (Table 4).
Going on to explore the factors associated with 
high self-reported compliance, the belief that hy-
pertension was curable was significantly (p=0.023) 
associated with high self-reported compliance, with 
55.6% of those who said ‘Yes’ versus 51.6% of those 
who answered ‘No’ and 71.3% of those who said 
'Do not know' showing high self-reported compli-
ance. Also,  a  lower  proportion  of  those  who 
believed  that  hypertension  medication  can  be 
stopped after a while showed high self-reported 
compliance  (49.5%  vs  60.2%  of  those  who  an-
swered ‘No’ and 66.7% of those who did not know) 
but this was not significant (p=-0.090) (Table 5).
Several potential factors that could affect compli-
ance with treatment, including having a fami- 
ly member with hypertension or who has expe-
rienced  complications  from  hypertension,  got 
support from family members and friends were 
explored in the present project. Most of these 
factors, including having a family member with hy-
pertension and support from family members and 
friends, were associated with compliance in gen-JHPN 624
Osamor PE and Owumi BE Treatment compliance in hypertension
Table 5. Relationships between other beliefs about hypertension and high self-reported compliance
Belief about hypertension
High self-reported compliance
 % χ² p value
Hypertension is preventable 57.0 4.004 0.135
Hypertension is curable 55.6 7.561 0.023
Hypertension is serious 58.2 0.877 0.645
Hypertension can lead to complications 58.5 1.152 0.562
Hypertension-related complications can be prevented 50.0 2.941 0.230
A person on treatment can stop taking medication 
after some time 49.5 4.812 0.090
Table 6. Relationships between other factors and treatment compliance
Variable Response
Compliance (%)
χ² p value High Medium Low
Has a family member with 
hypertension
Yes
No
Do not know
49.3
61.7
45.5
23.3
13.5
12.1
27.4
24.9
42.4
10.146 0.038
Has a family member 
who has serious health 
problems due to 
hypertension
Yes
No
Do not know
36.4
61.2
48.4
21.2
14.9
9.7
42.4
23.9
41.9
12.060 0.017
Family members 
concerned about 
respondent’s hypertension
Not very 
concerned
Very  
concerned
Extremely 
concerned
Do not know
47.6
50.6
61.1
60.0
28.6
23.5
11.9
20.0
23.8
25.9
27.1
20.0
10.857 0.093
Family members helpful 
in reminding about 
medication
Not very 
helpful
Very helpful
Extremely 
helpful
Do not know
54.6
48.3
61.5
57.1
18.2
27.0
11.5
14.3
27.3
24.7
27.0
28.6
13.579 0.035
Friends concerned about 
respondent’s hypertension
Not very 
concerned
Very  
concerned
Extremely 
concerned
Do not know
49.0
50.9
80.3
33.3
10.8
27.6
10.2
0.0
40.2
21.6
9.5
66.7
62.203 <0.0001
Friends helpful in 
reminding about 
medication
Not very 
helpful
Very  helpful
Extremely 
helpful
Do not know
49.2
44.0
79.3
50.0
12.3
31.9
8.0
25.0
38.5
24.2
12.7
25.0
62.204 <0.0001
eral. As shown in Table 6, having family members 
with hypertension and having a family member 
who has suffered complications were not associa- 
ted with high self-reported compliance. On the 
other hand, having friends who were concerned 
about the respondent’s hypertension or who were 
helpful in reminding the respondent about taking 
medication was associated with high self-reported 
compliance.
The findings of the FGD on issues of drug com-
pliance showed that, in general, the respondents Volume 29 | Number 6 | December 2011 625
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Fig. Reasons given for poor compliance in focus groups 
‘Feeling better’
I do not take my medicine every-
day. People do not always follow 
what the doctor says. It is not only 
for hypertension, even for other 
sicknesses. If they say take medicine 
for ﬁve days, once we feel better by 
the third day, the person will stop. 
Even the doctors themselves, will 
they swallow medicine everyday?
‘Forgets to take medication’
Let me tell you the truth: 
it is not easy to be taking drugs 
every day. Sometimes, we forget, 
especially when you are rushing to 
go out. Sometimes we do not have 
the money to buy it.
Reasons given for
poor compliance
‘Cost’
Money is the major problem. In the hospital, they 
will ask you to pay for an ordinary card before you 
see the doctor. When they write drugs for you, 
there is no money to buy all. If you do not have 
money and you go to a private hospital, they will 
not even attend to you. That is why some people 
prefer to just go to a chemist and buy what they 
can afford, and some others prefer traditional 
medicine because you do not have to drink it every 
day, and it is less-expensive.
perceived antihypertensive medications to be 
necessary but indicated those factors that hindered 
compliance with treatment. The major factors 
identified in the FGDs included: (a) Costs: medi-
cations were expensive compared to income, and 
some participants could only buy the quantity of 
medication they could afford instead of the full 
prescription (for example, two weeks instead of 
four weeks). This was the factor that was most em-
phasized; (b) Since having high blood pressure did 
not make them feel sick, respondents may ques-
tion the rationale for daily treatment without an 
end in sight. Even after they became aware of their 
hypertension  and  had  been  on  treatment  for  a 
while, this rationale persisted, and they often took 
their medication sporadically and, in some cases, 
stopped taking their medication after some time; 
and (c) Difficulty with the idea and practice of 
taking a medication every day for life. First, the 
idea of taking a medication daily for life meant that 
there was no cure, and in any case, many did not 
see the reason for continuing to take medication 
when they felt better or their blood pressure was 
controlled. Second, the participants said that 
they sometimes forgot to take their medication. 
These were the three major themes that emerged 
from the FGDs. Discussants' quotes that illustrate 
these obstacles are shown in the Figure. 
DISCUSSION
Compliance with treatment is a very important is-
sue in the successful control of hypertension and 
prevention of complications. In prescribing medi-
cation, compliance usually means “the extent to 
which the patient takes the medication as pre-
scribed” (19). A number of factors influence com-
pliance. The common belief that patients are solely 
responsible for taking their treatment is misleading 
and often reflects a misunderstanding of how other 
factors affect people’s behaviour and capacity to ad-
here to their treatment. 
Belief in the necessity of antihypertensive medi-
cation was high among the respondents, and the 
majority believed that it was necessary to take anti-
hypertensive medication even if one does not feel 
sick. About 19% believed that one should only take 
medication when there are symptoms and had 
strong concerns about the potential adverse effects 
of taking medication every day or did not see the JHPN 626
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need for taking medication when one is not feel-
ing ill. This finding also provides a preliminary in-
sight into the mechanism by which beliefs relating 
to medication might influence compliance. Some 
of these findings were similar to those reported in 
previous studies (20,21). Familoni et al., in a 2004 
study in Nigeria, reported that only about one-
third of patients knew that hypertension should 
ideally be treated for life, and 58.3% believed that 
antihypertensive drugs should be used only where 
there are ‘symptoms’ while the remaining 6.3% 
believed that the treatment should be for a period 
of time and not for life (22). Although it has been 
suggested that it is sometimes possible to withdraw 
drug therapy and continue lifestyle-modification 
after several years (23), the consensus is that almost 
all who are hypertensive before treatment will be-
come hypertensive again if treatment is stopped. 
This practice has sometimes resulted in disastrous 
consequences. 
There are many concepts that refer to compliance, 
for example ‘compliance’, ‘adherence’, ‘commit-
ment’, and ‘concordance’. According to Kontz, the 
most important thing is how the content of the con-
cept is defined (24). A major factor accounting for 
the inadequate treatment of hypertension is poor 
compliance. The findings of this study revealed 
that almost half of the respondents reported high 
compliance  with  treatment  with  drug,  and  86% 
claimed high compliance with keeping their ap-
pointments with doctors. Reasons for compliance 
with treatment include fear of the complications of 
hypertension and the desire to control blood pres-
sure. Benson, in 2002, reported that patients com-
ply with medication regimen for various reasons, 
including perceived benefits of medication, fear of 
complications associated with hypertension, and 
feeling better on medication (21). The latter reason 
is contrary to the generally-held belief among phy-
sicians that hypertension is a largely asymptomatic 
disease (25).
Interestingly, about one-half of the study respond-
ents were non-compliant to their medication. 
The results of the FGDs suggest that the decision 
to stop using antihypertensive medication is in-
fluenced by the beliefs the respondents hold con-
cerning these medications. The identification of 
the factors determining non-compliance and a 
better knowledge about them could allow the im-
plementation of measures that could enable their 
correction and providing the adequate control of 
blood-pressure levels. In this study, reasons for non-
compliance with medication are multifactorial and 
range from low level of knowledge regarding hy-
pertension as a disease and lack of adequate guid-
ance to socioeconomic aspects. The identification 
of side-effects of treatment used represents another 
cause of non-compliance with treatment. This 
finding lays credence to the submission of Hyman 
and Pavlik that a primary reason given for stopping 
medication relates to adverse effects, although the 
patient’s knowledge about the disease, attitudes to-
wards treatment of an often asymptomatic condi-
tion, and personal health beliefs, together with cost 
of medications and the availability of healthcare, 
are major contributors (12). One central theme that 
runs through the data in this study is the issue of 
socioeconomic status of the respondents. Finan-
cial hardship is a significant barrier to complying 
with treatment and is a contributory factor to non-
compliance. If people are hungry, nothing matters, 
except food. People either take medication very 
late when they have had something to eat or forget 
about it while trying to deal with other problems of 
poverty. This finding corroborates the observed as-
sociation among poor compliance, ignorance, and 
lack of funds for the purchase of drugs reported by 
Isezuo and Opara (26).
While stress and anxiety were the two most com-
mon perceived causes of hypertension among the 
respondents, the findings showed that those who 
held these beliefs did not show better compliance 
than others. However, those who did not know 
the cause of hypertension showed better compli-
ance with medication than others. This implies 
that not having preconceived ideas about the cause 
of hypertension made it more likely that the res- 
pondents would comply with treatment. This ob-
servation was also common to other beliefs about 
hypertension (being curable, preventable, serious, 
leading to complications, and so on) where those 
who responded ‘Do not know’ showed a tendency 
to better compliance. Other studies that have in-
vestigated the relationship between beliefs and 
compliance reported that patient’s belief and lack 
of knowledge, along with other factors, influenced 
their response to treatment (27,28).
Social support networks are important in the long-
term management of chronic conditions, such as 
hypertension, which requires a radical and life-long 
change in the lifestyle of the affected person. In the 
present study, those who had support from friends 
or family members (concerned about their illness, 
giving reminders about medication) had better 
compliance with treatment than those who did 
not, although this difference was the greatest for 
those who had the support of friends. This is an 
important finding and is consistent with what has 
been reported for multiple chronic diseases in sev-Volume 29 | Number 6 | December 2011 627
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eral parts of the world (29). Interestingly, the evi-
dence from the present study shows that support 
from friends is a stronger factor influencing high 
self-reported compliance than support from fami- 
ly members. This may be a reflection of the fact 
that most people in the community (and in cities 
in general) see, talk, and interact more with their 
friends than with their family members who do 
not live nearby. Another explanation may be that 
those with hypertension are more likely to discuss 
their health problems with their friends than with 
their family members, thereby inadvertently limit-
ing the support they could receive from the latter. 
Limitation
A potential limitation of this study is that compli-
ance was measured using self-report and, therefore, 
suffers from the problems of recall. Inclusion of 
methods, such as pill-counts or more sophisticated 
electronic methods, may have helped more accu-
rately assess compliance. However, this was not 
feasible within the context of a community-based 
study. Nonetheless, the study provides useful data 
in this important area of compliance to therapy for 
a non-communicable disease.
Conclusions 
It is concluded that the control of hypertension is 
still sub-optimal in this community, with only one-
half of the affected persons reporting high compli-
ance with treatment. The factors associated with 
high self-reported compliance included: regular 
clinic attendance, not using non-Western prescrip-
tion medication, and having social support from 
family members or friends who were concerned 
about the respondent’s hypertension or who were 
helpful in reminding the respondent about taking 
medication. Most respondents believed that hyper-
tension is curable with the use of both orthodox 
and traditional medicines and that a patient who 
‘feels well’ could stop using antihypertensive medi- 
cation. On the other hand, specific beliefs about 
the cause of hypertension were not associated with 
compliance. 
It is recommended that similar research be con-
ducted in developing countries on factors affecting 
compliance in hypertension and similar diseases 
that require life-long medication for control. Fur-
thermore, studies are needed on how such findings 
can be used for guiding local hypertension-control 
efforts. 
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